Qiming Weekly | Top 10 Updates from Qiming Venture Partners Portfolio Companies Vol.11, 2026.3.31
Celebrating milestone moments with Qiming Venture Partners' portfolio companies
Articles
Bangyun Medical Closes Nearly 100 Million Yuan Angel Round Led by Dalton Venture, Accelerating Upgrading and Global Innovation in Advanced Wound Closure | Dalton News
Dedicated to becoming a leading benchmark in China's domestic wound closure space.
5Y News | Syneron Bio Closes $150 Million Series B Round
Syneron Bio today announced the completion of its Series B funding round.
Yunqi Capital Leads Pre-A Round in ChipNet Power to Secure Position in Core AI Compute Track | Yunqi Partners
The Battle for Compute: From Performance to Efficiency and Security
NIMO Smart Glasses: Returning to the Essence of Wearability, First a Fashionable Pair of Glasses That Just Happens to Be Smart | Unity Ventures Portfolio
Hiding Smarts in a Great Pair of Glasses
Qiming Venture Partners Exclusively Leads Medway Medical's Series C Financing
a leading player in China's disposable endoscope market
A Lobster Restarted My Research Career
Can You Give AI a Topic and Let It Run the Entire Research Pipeline?
After 13 Years, Manycore Tech Clears Hong Kong Stock Exchange Listing Hearing | Qixing Chronicles
Set to become the "world's first publicly traded spatial intelligence company"
Source Code Rhythm Closes Over $150 Million Fund, Focuses on AI and Globalization
Focused on early-stage investing, with independent fundraising, independent decision-making, and independent operations.
Source Code Rhythm has raised over $150 million for its first fund and has launched RMB fund fundraising.
Another oversubscribed early-stage USD fund.